At Ceyone Life Sciences, we support clients through the late-phase and commercial stages of development, providing GMP-compliant batches that ensure seamless progression from pre-clinical to commercial supply. Our expertise in Tox Batches and First-in-Human (FIH) GMP Batches helps establish a solid foundation for successful clinical trials. With cutting-edge technology and strict compliance, we guarantee products that meet the highest safety and efficacy standards.
- Seamless Transition from Clinical to Commercial Scale
- Bridge Phase 2/3 clinical requirements to commercial-scale supply
- Process validation and Critical Process Parameter (CPP) qualification
- Comprehensive scale-up risk assessments and engineering controls
- Commercial-Scale cGMP Manufacturing
- Multi-ton bulk drug (API) and advanced intermediate production
- Modern reactor capabilities with versatile metallurgy (SS, GLR, Hastelloy)
- Controlled cleanroom environments for isolation, drying, and packaging
- Efficient batch and campaign-based manufacturing workflows
- Process Validation & Tech Transfer
- Formal Process Performance Qualification (PPQ) campaigns
- Control strategy implementation based on Quality by Design (QbD)
- Establishing critical quality attributes (CQAs) and operating ranges
- Analytical Lifecycle & Release Testing
- Validated analytical test methods (HPLC, GC, LC-MS, IC)
- Commercial batch release and retest interval establishment
- Formal ICH stability testing (long-term, intermediate, accelerated)
- Robust Supply Chain & Regulatory Alignment
- Sustainable raw material sourcing and backwards integration
- Complete CMC documentation to support NDA, ANDA, and MAA filings
- Support for global regulatory filings, inspections, and audit readiness
- Long-term supply agreements and proactive risk mitigation Why Choose Ceyone
Why Choose Ceyone ?
Commercial Scale & Capacity
Our multi-ton commercial manufacturing infrastructure is engineered to handle complex small-molecule programs with high reliability and efficiency.
Proven Tech Transfer
Structured technology transfer and process validation frameworks ensure rapid industrialization with minimal yield loss and no supply interruptions.
End-to-End Regulatory Support
Comprehensive CMC data packages and audit-ready facilities designed to meet global regulatory authority expectations.
Reliable Long-Term Supply
Integrated sourcing, proactive risk management, and robust infrastructure provide complete supply chain resilience for commercial products..
Popular questions
What are Ceyone's late-phase and commercial manufacturing capabilities?
Ceyone provides large-scale cGMP manufacturing, process validation (PPQ), analytical method validation, and commercial supply for small-molecule APIs and advanced intermediates.
What reactor capacities are available for commercial production?
Our manufacturing facilities feature multi-kilogram to multi-ton capacities equipped with diverse metallurgy, wide temperature capabilities, and controlled isolation units.
Does Ceyone support Process Performance Qualification (PPQ)?
Yes. Ceyone designs and executes complete PPQ campaigns with documented control strategies, CPP verification, and CQA monitoring.
How does Ceyone handle technology transfer for commercial products?
We utilize a structured tech transfer framework with dedicated project management, cross-functional teams, and scale-up engineering to ensure smooth transitions from pilot to commercial scale.
Can Ceyone support commercial regulatory filings?
Yes. Ceyone provides complete CMC documentation, DMF/CEP packages, and audit support for regulatory agencies worldwide.